-transparent.png){kind=logo}
Four muscarinic receptor antagonists with varying selectivities for the four pharmacologically-defined muscarinic receptor subtypes (M1-M4) were administered into the lateral ventricle to determine their relative potency in reducing tremulous jaw movements induced by i.p. injection of the muscarinic receptor agonist pilocarpine (4.0 mg/kg). All four muscarinic receptor antagonists reduced tremulous jaw movements in a dose-dependent manner, with the following rank order of potency: scopolamine > methoctramine > or = telenzepine > pirenzepine. This pattern is inconsistent with the rank order of affinity of these agents at the muscarinic M1 receptor, and is consistent with their rank order of affinity at muscarinic M2 or M4 receptors. Because tremulous jaw movements are related to striatal function, and the muscarinic M4 receptor is more predominant than the muscarinic M2 receptor as a post-synaptic receptor in striatum, the present results suggest that pilocarpine induces jaw movements due to muscarinic M4 receptor stimulation. In view of the hypothesized relation between parkinsonism and cholinomimetic-induced jaw movements, these data suggest that a centrally-acting muscarinic M4 receptor antagonist could be useful as an antiparkinsonian agent.
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
May 1999,
Brain research,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
July 2015,
Behavioural brain research,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
October 1994,
Pharmacology, biochemistry, and behavior,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
January 1997,
Pharmacology, biochemistry, and behavior,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
November 2014,
Pharmacology, biochemistry, and behavior,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
May 1998,
Physiology & behavior,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
April 2001,
Life sciences,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
January 1985,
British journal of pharmacology,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
March 1989,
British journal of pharmacology,
A J Mayorga, and
M S Cousins, and
J T Trevitt, and
A Conlan, and
G Gianutsos, and
J D Salamone
October 2007,
Psychopharmacology,
